Roald Øien is professor of special education and developmental psychology at the Arctic University of Norway and adjunct assistant professor at the Yale Child Study Center.
Roald Øien
Professor
Arctic University of Norway and Yale Child Study Center
From this contributor
Journal Club: Meta-analysis oversells popular autism screen
The Modified Checklist for Autism in Toddlers (M-CHAT) accurately flags autistic toddlers, a new systematic review and meta-analysis suggests, contrary to past evidence that the tool’s validity varies depending on a child’s age and traits. Experts weigh in on the discrepancy.
Journal Club: Meta-analysis oversells popular autism screen
By
Spectrum
14 March 2023 | 5 min read
Reimagining autism screening: A conversation with Roald Øien
The questionnaires used to screen for autism are far from perfect, and tweaking them may not be enough. Roald Øien wants researchers to find better solutions.
Reimagining autism screening: A conversation with Roald Øien
By
Laura Dattaro
21 December 2021 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read